Dynavax Technologies Corporation

Total Valuation

Dynavax Technologies Corporation carries a market capitalization of 1.82B, placing it among publicly traded companies globally. Its enterprise value stands at 852.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Dynavax Technologies Corporation currently has 117.36M shares outstanding.

Valuation Ratios

Dynavax Technologies Corporation trades at a trailing price-to-earnings ratio of 60.81. The price-to-sales ratio is 3.68, and the price-to-book ratio stands at -1.27.

Enterprise Valuation

On an enterprise value basis, Dynavax Technologies Corporation trades at an EV/EBITDA multiple of 28.75 and an EV/FCF ratio of 7.90. The EV/Sales ratio of 2.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.81 provides insight into valuation relative to core operating earnings.

Financial Position

Dynavax Technologies Corporation maintains a current ratio of 7.62, meaning it holds 7.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.36, indicating elevated leverage, while an interest coverage ratio of 4.41 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Dynavax Technologies Corporation has paid 2.79M in income taxes, reflecting an effective tax rate of 24.60.

Stock Price Statistics

Dynavax Technologies Corporation's stock has gained approximately 13.22133% over the past 52 weeks. The 50-day moving average sits at 13.69, while the 200-day moving average is 11.19.

Income Statement

Over the trailing twelve months, Dynavax Technologies Corporation generated 330.51M in revenue and converted that into -43.40M in net income, yielding earnings per share of -0.31. EBITDA reached 29.65M, while operating income came in at 21.41M.

Balance Sheet

Dynavax Technologies Corporation holds 647.82M in cash and equivalents against 285.02M in total debt, resulting in a net debt position of 100.79M. Total book value stands at -953.61M, with working capital of 707.49M providing operational flexibility.

Cash Flow

Dynavax Technologies Corporation produced 90.63M in operating cash flow over the past twelve months. After subtracting -10.09M in capital expenditures, free cash flow totaled 80.54M - equivalent to 0.66 per share.

Margins

Dynavax Technologies Corporation operates with a gross margin of 83.17, reflecting its pricing power and cost economics. The operating margin of 6.48 and net profit margin of -13.13 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Dynavax Technologies Corporation's most recent stock split took place on November 10, 2014 with a 10:1 split ratio.

Scores

Dynavax Technologies Corporation posts an Altman Z-Score of 1.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.